SK Holdings to acquire AMPAC Fine Chemicals
Submitted by:
Andrew Warmington
AMPAC Fine Chemicals (AFC), a leading US-based contract development and manufacturing organisation (CDMO) has announced
Catalent to acquire Juniper Pharmaceuticals
Submitted by:
Andrew Warmington
Catalent, Inc, a leading global provider of advanced delivery technologies and development solutions for drugs
Chemspec highlight: Pharma outsourcing – best practices
Submitted by:
Andrew Warmington
“Fail early and fail cheap” – this was the key message from Dr Magid Abou-Gharbia
CPhI Worldwide opens entries for 15th annual Pharma Awards
Submitted by:
Andrew Warmington
Winners will be announced live at the Gala Ceremony in Madrid at CPhI Worldwide with
Process innovation needs to be undertaken in early R&D phase, predicts ADC Bio
Submitted by:
Andrew Warmington
ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and
Gates Foundation and UK Government join CARB-X
Submitted by:
Andrew Warmington
The Bill & Melinda Gates Foundation and the UK Government’s Global Antimicrobial Resistance Innovation Fund (GAMRIF)
EU calls for global ban on cosmetics animal testing
Submitted by:
Andrew Warmington
Ministers of the European Parliament have called for an end to cosmetics animal testing and
DuPont and ADM open world-first FDME pilot production facility
Submitted by:
Andrew Warmington
DuPont Industrial Biosciences and Archer Daniels Midland Company (ADM) have opened the world’s first biobased
EU votes to ban neonicotinoids
Submitted by:
Andrew Warmington
EU member states have voted to impose a near- total ban on neonicotinoid insecticides –
Takeda and Shire settle on US$62 billion deal
Submitted by:
Andrew Warmington
After months of discussions, Japan’s Takeda Pharmaceutical Company has reached an agreement to acquire Shire